DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

DXCM DexCom, Inc.

Healthcare

Price
$83.39
Intrinsic value
$52.80
Buy price
$42.24
Discount
-57.9%
Overvalued

Live signals

Daily bars as of Oct 8, 2026

Nothing firing right now - no PAM pattern in the last 5 daily bars, and no DR1 support reclaim in the last 5 weekly bars. Technical confluence is WEAK (1/3) - see the chart below.

DCF walkthrough

Near-term growth (g1)17.01%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$1,748,700,000.00
Total debt
$1,398,400,000.00
Cash & STI
$1,947,000,064.00
Shares out.
390,100,000
Overvalued
Intrinsic value$52.80
Buy price (with MOS)$42.24
Current price$83.39
Discount to intrinsic value-57.9%

7-step quality scorecard

ROE quality
HIGH_CONSISTENT
Average ROE
25.0%
Current ROE
30.5%
Minimum ROE
16.0%
Debt quality
MODERATE
Debt / Equity
0.51x
Moat proxy
STRONG_PROXY
Cash-flow reliability
OK
Operating CF / Net income
1.75x

Technical chart

Confluence: WEAK (1/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
min(revenueCAGR,cfCAGR)
Valuation model
DCF_OCF
Debt as % of DCF PV
7%
Public economic interest
100.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.